| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10717544.2015.1040527 |
| P698 | PubMed publication ID | 26036724 |
| P2093 | author name string | Li Zhang | |
| Yue Qiu | |||
| Qin He | |||
| Mingqing Yuan | |||
| Huile Gao | |||
| P2860 | cites work | Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway | Q28214714 |
| The transferrin receptor part I: Biology and targeting with cytotoxic antibodies for the treatment of cancer | Q28257323 | ||
| Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review | Q29617388 | ||
| Drug delivery systems: entering the mainstream | Q29618136 | ||
| Codelivery of doxorubicin and paclitaxel by cross-linked multilamellar liposome enables synergistic antitumor activity | Q33598842 | ||
| Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells | Q33708231 | ||
| HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches | Q33760273 | ||
| Sequential steps in clathrin-mediated synaptic vesicle endocytosis. | Q33941586 | ||
| Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration | Q34043777 | ||
| Transduction peptides: from technology to physiology | Q34308241 | ||
| Enhancement of cell recognition in vitro by dual-ligand cancer targeting gold nanoparticles | Q34573279 | ||
| Nanoparticles in medicine: therapeutic applications and developments | Q34655287 | ||
| Surface antigens/receptors for targeted cancer treatment: the GnRH receptor/binding site for targeted adenocarcinoma therapy | Q35971889 | ||
| Transcellular protein transduction using the Tat protein of HIV-1. | Q36049575 | ||
| Recent advances in tumor-targeting anticancer drug conjugates. | Q36162882 | ||
| Transferrin receptor is negatively modulated by the hemochromatosis protein HFE: implications for cellular iron homeostasis | Q36350386 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| The role of surgery in treatment of stage IV melanoma | Q36569464 | ||
| Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers | Q37021750 | ||
| Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. | Q37363141 | ||
| Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer | Q37616813 | ||
| A myristoylated cell-penetrating peptide bearing a transferrin receptor-targeting sequence for neuro-targeted siRNA delivery | Q38862070 | ||
| Enhanced glioma targeting and penetration by dual-targeting liposome co-modified with T7 and TAT. | Q38945641 | ||
| Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals | Q38988688 | ||
| Tumor cells and neovasculature dual targeting delivery for glioblastoma treatment | Q39042866 | ||
| Glioma-homing peptide with a cell-penetrating effect for targeting delivery with enhanced glioma localization, penetration and suppression of glioma growth | Q39080267 | ||
| Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy | Q39326137 | ||
| Liposome formulated with TAT-modified cholesterol for improving brain delivery and therapeutic efficacy on brain glioma in animals. | Q39468777 | ||
| Dual-ligand modification of PEGylated liposomes shows better cell selectivity and efficient gene delivery | Q39568717 | ||
| A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system. | Q39574639 | ||
| pH-Sensitive degradable polymersomes for triggered release of anticancer drugs: a comparative study with micelles | Q39791406 | ||
| The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles | Q39910851 | ||
| Effective anti-tumor activity of oxaliplatin encapsulated in transferrin-PEG-liposome | Q40104855 | ||
| A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers | Q40244491 | ||
| Anti-neovascular therapy by use of tumor neovasculature-targeted long-circulating liposome. | Q40474868 | ||
| Folate receptor-mediated targeting of liposomal drugs to cancer cells | Q40550326 | ||
| Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake | Q43067391 | ||
| A synergistic combination therapy with paclitaxel and doxorubicin loaded micellar nanoparticles | Q43463621 | ||
| Cell penetrating peptide tethered bi-ligand liposomes for delivery to brain in vivo: Biodistribution and transfection | Q44118023 | ||
| Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin | Q44558769 | ||
| Study and evaluation of mechanisms of dual targeting drug delivery system with tumor microenvironment assays compared with normal assays. | Q46375000 | ||
| Saturation of the endocytic pathway for the transferrin receptor does not affect the endocytosis of the epidermal growth factor receptor. | Q52196657 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | doxorubicin | Q18936 |
| paclitaxel | Q423762 | ||
| P304 | page(s) | 1171-1183 | |
| P577 | publication date | 2015-06-03 | |
| P1433 | published in | Drug Delivery | Q5308838 |
| P1476 | title | Targeted delivery of transferrin and TAT co-modified liposomes encapsulating both paclitaxel and doxorubicin for melanoma | |
| P478 | volume | 23 |
| Q38733989 | A review of the ligands and related targeting strategies for active targeting of paclitaxel to tumours |
| Q90418931 | Cell-Penetrating Peptide and Transferrin Co-Modified Liposomes for Targeted Therapy of Glioma |
| Q90731539 | Development and screening of brain-targeted lipid-based nanoparticles with enhanced cell penetration and gene delivery properties |
| Q64998074 | Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. |
| Q36978587 | Nanoparticles and nanofibers for topical drug delivery |
| Q51016018 | PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations. |
| Q92156872 | Transferrin-bearing liposomes entrapping plumbagin for targeted cancer therapy |
| Q92591557 | Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells |
Search more.